JPS599159B2 - New substance 477-2h and its manufacturing method - Google Patents

New substance 477-2h and its manufacturing method

Info

Publication number
JPS599159B2
JPS599159B2 JP3968278A JP3968278A JPS599159B2 JP S599159 B2 JPS599159 B2 JP S599159B2 JP 3968278 A JP3968278 A JP 3968278A JP 3968278 A JP3968278 A JP 3968278A JP S599159 B2 JPS599159 B2 JP S599159B2
Authority
JP
Japan
Prior art keywords
culture
water
medium
column
substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP3968278A
Other languages
Japanese (ja)
Other versions
JPS54132550A (en
Inventor
清 中山
広 加瀬
令匡 高沢
重人 北村
公勝 白幡
孝男 飯田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Priority to JP3968278A priority Critical patent/JPS599159B2/en
Publication of JPS54132550A publication Critical patent/JPS54132550A/en
Publication of JPS599159B2 publication Critical patent/JPS599159B2/en
Expired legal-status Critical Current

Links

Description

【発明の詳細な説明】 本発明は新規物質477−2れに関する。[Detailed description of the invention] The present invention relates to novel substance 477-2.

本発明は又、ミクロモノスポラ属に属し、477−2れ
を生産する能力を有する微生物を栄養培地に培養し、培
地中に477−2れが検出される迄培養し、生成蓄積し
た477=2れを採取することを特徴とする477−2
れの製造法に関する。従来ミクロモノスポラ属の微生物
の培養物からジエンタマイシン等の抗生物質が得られる
ことが知られている。本発明者らはミクロモノスポラ属
の微生物の代謝生産物について研究し、ある菌の培養物
中に公知物質と区別される抗菌性を有する化合物を見い
出した。この化合物について詳細に物理化学的性質を検
討した結果、該物質が次の構造式を有する新規物質であ
ることを見出し、477−2れと命名した。二エい一゜
゛゜゛ lNHCH。
The present invention also relates to culturing a microorganism belonging to the genus Micromonospora and having the ability to produce 477-2 in a nutrient medium, and culturing until 477-2 is detected in the medium, thereby producing and accumulating 477= 477-2 characterized by collecting 2.
Regarding the manufacturing method. It has been known that antibiotics such as dientamicin can be obtained from cultures of microorganisms of the genus Micromonospora. The present inventors have studied the metabolic products of microorganisms of the genus Micromonospora, and have discovered a compound in a culture of a certain bacterium that has antibacterial properties that are distinct from known substances. As a result of detailed examination of the physicochemical properties of this compound, it was discovered that it is a new substance having the following structural formula, and it was named 477-2. 2E1゜゛゜゛lNHCH.

NH2NH2 本発明によれば477−2hはミクロモノスポラ属に属
し、477−2hを生産する能力を有する微生物を培地
に培養し、477−2hが検出される迄培養し、培養物
から該物を適当な方法で単離精製することによつて得ら
れる。
NH2NH2 According to the present invention, 477-2h belongs to the genus Micromonospora, and a microorganism capable of producing 477-2h is cultured in a medium, the culture is continued until 477-2h is detected, and the microorganism is extracted from the culture. It can be obtained by isolation and purification using an appropriate method.

477−2hは遊離の塩基性物質であり、酸1〜4当量
との反応によつてモノ、ジ、トリ、テトラ塩例えば塩酸
塩、臭化水素酸塩、ヨウ化水素酸塩、硫酸塩、リン酸塩
、炭酸塩、硝酸塩、酢酸塩、フマル酸塩、リンゴ酸塩、
クエン酸塩、マンデル酸塩、アスコルビン酸塩、酒石酸
塩、コハク酸塩等の塩に変換される。
477-2h is a free basic substance which, by reaction with 1 to 4 equivalents of acid, forms mono-, di-, tri-, and tetra-salts such as hydrochloride, hydrobromide, hydroiodide, sulfate, phosphates, carbonates, nitrates, acetates, fumarates, malates,
It is converted into salts such as citrate, mandelate, ascorbate, tartrate, and succinate.

477−2h及びその酸塩はサガマイシン等の抗生物質
を製造する際の前駆物質として有用でありまた、広範囲
のグラム陽性菌およびグラム陰性菌に対し弱い抗菌活性
を有し、実験器具の洗浄殺菌に有用であり、又洗剤と共
に組合せて洗浄剤として用いることができる。
477-2h and its acid salts are useful as precursors in the production of antibiotics such as sagamycin, and have weak antibacterial activity against a wide range of Gram-positive and Gram-negative bacteria, making them useful for cleaning and sterilizing laboratory equipment. It is useful and can also be used in combination with detergents as a cleaning agent.

本発明にかかわる477−2hの遊離塩基の理化学的性
状は次の通りである。
The physicochemical properties of the free base of 477-2h related to the present invention are as follows.

(1)塩基性の白色粉末 (2)元素分析値 (3)分子量 630 (4)分子式 C24H46N4O,, (5)紫外部吸収スベクトルリ本物質の水溶液の紫外部
吸収スペクトルは220〜360nmの間で特徴的な吸
収極大を示さず、末端吸収を示すのみである。
(1) Basic white powder (2) Elemental analysis value (3) Molecular weight 630 (4) Molecular formula C24H46N4O,, (5) Ultraviolet absorption Svectori The ultraviolet absorption spectrum of an aqueous solution of this substance is characteristic between 220 and 360 nm. It does not show a typical absorption maximum, but only shows terminal absorption.

(6)本物質は水にきわめて易溶、メタノールにも溶け
、エタノール、アセトンにもやや溶けるが、クロロホル
ム、ベンゼン、酢酸エチル、酢酸ブチル、エーテル、ブ
タノール、石油エーテル、n−ヘキサンなどの有機溶媒
には不溶である。
(6) This substance is extremely soluble in water, soluble in methanol, and slightly soluble in ethanol and acetone, but organic solvents such as chloroform, benzene, ethyl acetate, butyl acetate, ether, butanol, petroleum ether, and n-hexane It is insoluble in

(7)呈色反応:ニンヒドリン反応:陽性 過マンガン酸カリ反応:陽性 ビウレツト反応:陰性 坂口反応:陰性 (8)本物質の重水中(PD9.8)でのプロトン核磁
気共鳴スペクトルは次の値を示す。
(7) Color reaction: Ninhydrin reaction: Positive Potassium permanganate reaction: Positive Biuretz reaction: Negative Sakaguchi reaction: Negative (8) The proton nuclear magnetic resonance spectrum of this substance in heavy water (PD9.8) has the following values. shows.

単位はPpmOl.lO−1.50(1H,.m)、1
.70〜2.20(1H..m)、2.52(3H,.
s)、2.60〜3.10(4H)、3.10〜4.2
0(17H)、4.94(1H,.d,.J=3.4H
z)、5.03(1H,.d,.J=3.9Hz)、5
.25(1H,.d,.J=3.4Hz)9)本物質の
重水中(PD9.9)での炭素核磁気共鳴スペクトルは
次の値を示す。
The unit is PpmOl. lO-1.50 (1H,.m), 1
.. 70-2.20 (1H..m), 2.52 (3H..m)
s), 2.60-3.10 (4H), 3.10-4.2
0(17H), 4.94(1H,.d,.J=3.4H
z), 5.03 (1H, .d, .J=3.9Hz), 5
.. 25 (1H,.d,.J=3.4Hz)9) The carbon nuclear magnetic resonance spectrum of this substance in heavy water (PD9.9) shows the following values.

単位はPpml lOl.9、100.6、99.0、88.8、87.
6、75.0、74.6、73.9、72.7、72.
3、72.2、70.8、70.5、70.4、68.
3、67.2、62.9、62.7、61.3、56.
1、51.5、50.3、36.4、33.9以上の物
理化学的性質から本化合物は次の構造式を有すると考え
られる。
The unit is Ppml lOl. 9, 100.6, 99.0, 88.8, 87.
6, 75.0, 74.6, 73.9, 72.7, 72.
3, 72.2, 70.8, 70.5, 70.4, 68.
3, 67.2, 62.9, 62.7, 61.3, 56.
From the physicochemical properties of 1, 51.5, 50.3, 36.4, and 33.9, the present compound is considered to have the following structural formula.

0)本物質の各種展開剤によるシリカゲル薄層クロマト
グラフイ一〔E.Merk製KieselGel6O(
室温で行う。
0) Silica gel thin layer chromatography of this substance using various developing agents [E. Kiesel Gel 6O made by Mark (
Perform at room temperature.

展開時間3時間)〕のRf値が以下に示される。なお比
較のためにジエンタマイシンAを選び、そのRf値を併
記する。いずれも容量比を示す。本発明において用いら
れる微生物はミクロモノスポラ属に属し、477−2h
を生産する能力を有する微生物ならいずれでもよい。
The Rf value of the sample (deployment time: 3 hours)] is shown below. For comparison, dientamicin A was selected and its Rf value is also listed. Both indicate capacity ratio. The microorganism used in the present invention belongs to the genus Micromonospora, and 477-2h
Any microorganism that has the ability to produce can be used.

好ましい菌の属する種はミクロモノスポラ・サガミエン
シスである。具体的好ましい菌の例はミクロモノスポラ
・サガミエンシスG−477である。この菌は千葉県稲
毛市に所在する工業技術院、微生物工業技術研究所に寄
託され、微工研菌寄第4459号と特定されている。こ
の菌の属する種の菌学的性質は特公昭50−39155
号に記載されている。微生物の培養法としては通常の放
線菌の培養法が用いられる。培地として炭素源、窒素源
、無機塩類を適度に含有する培地が用いられる。炭素源
としてはブドウ糖、澱粉、デキストリン、マンノース、
フラグドーズ、シユークローズ、糖蜜などが単独または
組み合わせて用いられる。無機および有機窒素源として
は塩化アンモニウム、硫酸アンモニウム、尿素、硝酸ア
ンモニウム、硝酸ナトリウム、などがまた天然窒素源と
してはペプトン、肉工キズ、酵母工キズ、乾燥酵母、コ
ーン・スチープ・りカー、大豆粉、カザミノ酸、ソリユ
プルペジタプル・プロテイン、綿実ガスなどが単独また
は組み合せて用いられる。そのほか必要に応じて食塩、
塩化カリウム、炭酸カルシウム、燐酸塩などの無機塩類
を適当に加えるほか、使用菌の生育や477−2hの生
産を促進する有機物や無機物を適当に加えることができ
る。培養法としては、液体培養法、とくに深部撹拌培養
法がもつとも適している。
A preferred species of bacteria is Micromonospora sagamiensis. A specific example of a preferred bacterium is Micromonospora sagamiensis G-477. This bacterium has been deposited at the Institute of Microbial Technology, Agency of Industrial Science and Technology, located in Inage City, Chiba Prefecture, and has been identified as Microbiological Research Institute No. 4459. The mycological properties of the species to which this bacterium belongs are published in Japanese Patent Publication No. 50-39155.
listed in the number. As a method for culturing microorganisms, a conventional method for culturing actinomycetes is used. A medium containing appropriate amounts of carbon source, nitrogen source, and inorganic salts is used as the medium. Carbon sources include glucose, starch, dextrin, mannose,
Flagdose, syrup, molasses, etc. are used alone or in combination. Inorganic and organic nitrogen sources include ammonium chloride, ammonium sulfate, urea, ammonium nitrate, sodium nitrate, etc. Natural nitrogen sources include peptone, meat factory scratches, yeast factory scratches, dried yeast, corn steep liquor, soy flour, Casamino acids, solupulpegitapuru protein, cottonseed gas, etc. are used alone or in combination. In addition, salt as needed,
In addition to appropriately adding inorganic salts such as potassium chloride, calcium carbonate, and phosphates, organic or inorganic substances that promote the growth of the bacteria used and the production of 477-2h can be added as appropriate. As a culture method, a liquid culture method, especially a deep agitation culture method, is suitable.

培養温度は25〜40℃、PHは中性付近で培養するこ
とが望ましい。液体培養で通常1日ないし12日間培養
を行うと477−2hが培養液中に蓄積される。培養液
申の生成量が最大に達したときに、培養を停止し、培養
液中より目的物を精製単離する。培養液からの477−
2hの精製単離は微生物代謝産物を、その培養液から単
離するためにふつう用いられる分離・精製の方法が利用
される。ノ477−2hは、前述の如く水溶性、塩基性
物質なので、いわゆる水溶性・塩基性抗生物質の精製に
よく用いられる方法により精製を行うことができる。
It is desirable to culture at a culture temperature of 25 to 40°C and a pH near neutral. When culture is carried out in liquid culture for usually 1 to 12 days, 477-2h is accumulated in the culture solution. When the amount of culture fluid produced reaches the maximum, the culture is stopped and the target product is purified and isolated from the culture fluid. 477- from culture solution
The 2-h purification and isolation utilizes separation and purification methods commonly used to isolate microbial metabolites from their culture fluids. Since No. 477-2h is a water-soluble, basic substance as described above, it can be purified by a method commonly used for purifying so-called water-soluble/basic antibiotics.

すなわちカチオン交換樹脂による吸脱着法、セルロース
カラムクロマトグラフイ一、セフアデツクスLH−20
カラムによる吸脱着法、シリカゲルクロマトグラフイ一
、カーボンクロマトグラフイ一などの方法を適当に組み
合わせて行うことができる。また本物質の遊離塩基また
は硫酸塩を単離・精製することができる。次に培養液か
ら477−2hの精製・単離の一例を示す。
Namely, adsorption/desorption method using cation exchange resin, cellulose column chromatography, Sephadex LH-20
This can be carried out by appropriately combining methods such as adsorption/desorption using a column, silica gel chromatography, and carbon chromatography. It is also possible to isolate and purify the free base or sulfate salt of this substance. Next, an example of purification and isolation of 477-2h from a culture solution will be shown.

培養終了後、培養液から固形物を除き、得られる培養液
を弱アルカリ性に調整した後カチオン交換樹脂アンバー
ライトIRC−50(NH4+型)(ローム・アンド・
ハース社製、USA)を充填したカラムに通して、稀ア
ンモニア水で溶出し溶出液を適当量のフラクシヨンにと
る。
After culturing, solid matter was removed from the culture solution, and the resulting culture solution was adjusted to weak alkalinity. Then, cation exchange resin Amberlite IRC-50 (NH4+ type) (ROHM & Co., Ltd.) was added.
Pass the column through a column packed with HAAS Co., USA), elute with dilute ammonia water, and collect the eluate in an appropriate amount of fractions.

477−2hを含む区分を集め減圧下で濃縮乾固すると
粗477−2hの白色粉末を得る。
The fractions containing 477-2h were collected and concentrated to dryness under reduced pressure to obtain a crude white powder of 477-2h.

つぎにこの粗粉末をシリカゲルクロマトグラフイ一によ
り精製する。シリカゲルをn−ブタノール、エタノール
、濃アンモニア水(8:10:7)に懸濁しカラムにつ
め、これに粗粉末をのせ同一組成のソルベントで溶出す
る。477−2hの画分を集め濃縮乾固後、残渣を少量
の水に溶かしてから弱アルカリ性に調整した後アンバー
ライトIRC−50(NH4+型)を充填したカラムに
通す。
Next, this crude powder is purified by silica gel chromatography. Silica gel is suspended in n-butanol, ethanol, and concentrated aqueous ammonia (8:10:7), packed into a column, the coarse powder is placed on the column, and the column is eluted with a solvent of the same composition. The fractions of 477-2h were collected and concentrated to dryness, and the residue was dissolved in a small amount of water, adjusted to be slightly alkaline, and passed through a column packed with Amberlite IRC-50 (NH4+ type).

水洗後1N−アンモニア水で溶出し、477−2hを含
む区分を集めて減圧下で濃縮後凍結乾燥を行うと精製さ
れた477−2hを得ることができる。477−2hを
サガミシンの製造に用いる例として、ミクロモノスポラ
・サガミエンシス・バリタス・ノンレデユカンスATC
C2l949を用い特開昭51−38490号明細書の
実施例3と同様に実施しサガミシンを製造する際、発酵
培地中に477−2hを250μy/mlを加えた培地
を用いて培養するとサガミシンの収量は4772hを用
いない場合の2倍に増大する。
After washing with water, elute with 1N aqueous ammonia, collect fractions containing 477-2h, concentrate under reduced pressure, and freeze-dry to obtain purified 477-2h. As an example of using 477-2h in the production of Saga sewing machines, Micromonospora sagamiensis varitus nonreducans ATC
When producing Sagamisin using C2l949 in the same manner as in Example 3 of JP-A No. 51-38490, the yield of Sagamisin is increased by culturing in a fermentation medium containing 250 μy/ml of 477-2h. is twice as large as when 4772h is not used.

以下に実施例によつて本発明の477−2hの製造法に
ついて具体的に説明する。
EXAMPLES The method for producing 477-2h of the present invention will be specifically explained below using Examples.

実施例 1 A.ミクロモノスポラ・サガミエンシスG477の培養
:種菌としてミクロモノスポラ・サガミエンシス(Mi
crOnOnOspOrasagamiensis)G
−477(微工研菌寄第4459号)を用いる。
Example 1 A. Cultivation of Micromonospora sagamiensis G477: Micromonospora sagamiensis (Mi
crOnOnOspOrasagamiensis)G
-477 (Feikoken Bibori No. 4459) is used.

第1、2および3種培地として、スタピローズK〔松谷
化学(株)製〕2%(w/v)(以下同じ)、グルコー
ス0.5%、ペプトン0.5%、酵母工キズ0.5%、
肉工キズ0.3%、炭酸カルシウム0.2%(殺菌前P
H8.O)の培地を用いる。
The 1st, 2nd, and 3rd types of media were Stapyrose K (manufactured by Matsutani Chemical Co., Ltd.) 2% (w/v) (the same applies hereinafter), glucose 0.5%, peptone 0.5%, yeast yeast scratch 0.5 %,
Meat processing scratches 0.3%, calcium carbonate 0.2% (before sterilization P
H8. Use the medium of O).

種菌1白金耳を、大型試験管中10m1の上記培地に植
菌し、30℃で3日間振盪培養する。この種培養液10
m1を21バツフル付きエルレンマイャーフラスコ中に
入つた350Tn1の第2種培地に植菌する。第2種培
養は30℃で2日間振盪培養する。この種培養液1.5
1(フラスコ5本分)を301容量のジヤーフアーメン
タ一中の第3種培地151に植菌し、34℃で24時間
通気撹拌方式(回転数250rpm、通気量151/M
m)により培養を行う。最後にこの第3種培養液15.
eを3001容量のタンク中の発酵培地1501に植菌
する。発酵培地組成はシユークローズ4%、ソイビーン
ミール(SOybeanmeal)1%、フアーマメデ
イア(Pharmanedia)(TradersOl
lmilcOmpa製U.S.A.)2%、コーンミー
ル(COrnmeal)1%、大豆カゼイン0.5%、
燐酸2カリウム0.025%、硫酸マグネシウム0.0
5%、カルシウムフィチッ0.2%、コーンオイル(C
OrnOil)0.1%、硫酸第1鉄0.015%、L
−グルタミン0.0001%、L−シスチン0.005
%、β−アラニン0.005%、ニコチン酸0.000
5%、パントテン酸カルシウム0.0005%、硫酸亜
鉛(7水塩)0.0005%、カリウム明ばん(24水
塩)0.001%、モリブデン酸アンモニウム(4水塩
)0.025%(殺菌前PH8.O)の培地を用いる。
A platinum loopful of seed culture 1 is inoculated into 10 ml of the above medium in a large test tube, and cultured with shaking at 30°C for 3 days. This seed culture solution 10
m1 is inoculated into a second type medium of 350Tn1 placed in an Erlenmeyer flask with 21 bottles. The second type culture is cultured with shaking at 30°C for 2 days. This seed culture solution 1.5
1 (for 5 flasks) was inoculated into Type 3 medium 151 in a 301-capacity Jarfurmenta 1, and incubated at 34°C for 24 hours using an aeration stirring method (rotation speed 250 rpm, aeration rate 151/M).
Culture is carried out according to m). Finally, this third type culture solution 15.
Fermentation medium 1501 in a 3001 capacity tank is inoculated with the following. The fermentation medium composition was 4% Soucrose, 1% Soybeanmeal, and Pharmanedia (TradersOl).
lmilcOmpa U. S. A. ) 2%, cornmeal 1%, soybean casein 0.5%,
Dipotassium phosphate 0.025%, magnesium sulfate 0.0
5%, calcium phyto 0.2%, corn oil (C
OrnOil) 0.1%, ferrous sulfate 0.015%, L
-Glutamine 0.0001%, L-cystine 0.005
%, β-alanine 0.005%, nicotinic acid 0.000
5%, calcium pantothenate 0.0005%, zinc sulfate (7 hydrate) 0.0005%, potassium alum (24 hydrate) 0.001%, ammonium molybdate (4 hydrate) 0.025% (sterilization) Use a medium with a pH of 8.0.

この発酵は34℃で6日間通気攪拌培養方式(回転数1
80rpm、通気量1501/Mi!t)により行う。
B.477−2hの精製単離 前記培養終了後、培養液のPHを12N一硫酸でPH2
.Oに調整し、80℃で10分間加熱撹拌する。
This fermentation was carried out at 34℃ for 6 days using an aerated agitation culture method (rotation speed: 1
80 rpm, ventilation amount 1501/Mi! t).
B. 477-2h purification and isolation After the completion of the above culture, the pH of the culture solution was adjusted to PH2 with 12N monosulfuric acid.
.. The mixture was heated and stirred at 80°C for 10 minutes.

そののち沢過助剤としてラジオライト#600(昭和化
学工業(株)製)を2kg加え、菌体を沢別する。この
沢液をダイヤイオンHPK−25;(NH4+型)(三
菱化成製)101を充填したカラムに通し、流出液は捨
てる。
Thereafter, 2 kg of Radiolite #600 (manufactured by Showa Kagaku Kogyo Co., Ltd.) was added as a filter aid, and the bacterial cells were separated. This filtrate is passed through a column filled with Diaion HPK-25 (NH4+ type) (manufactured by Mitsubishi Kasei) 101, and the effluent is discarded.

水で樹脂を洗滌後2N−アンモニア水で溶出し、477
−2hを含む画分を減圧下で301まで濃縮する。濃縮
液を6N塩酸でPH8.Oに調整した後、アンバーライ
トIRC−50(NH4+型)41を充填したカラムに
通し、水洗後2N−アンモニア水で溶出し、477−2
hを含む区分を減圧下で濃縮乾固する。残渣を水に溶か
し、PH8.Oに調整した後、アンバーライトCG一5
0タイプI(NH4+型)(ローム・アンド・ハース社
製U.s.A)1000mtを充填したカラムに通し水
洗後0.2M塩化アンモニウムを含む0.1Nアンモニ
ア水にて溶出する。始めに数個の微量成分が溶出された
あと、477−2hを含む区分が溶出されてくる。この
画分を集めて6N一塩酸にてPH7.8に調整後アンバ
ーライトIRC−50(NH4+型)200rfL1を
充填したカラムに通塔し、水洗後1N−アンモニア水で
溶出する。477−2hを含む区分を濃縮し凍結乾燥を
行うと、粉末7.5tが得られた。
After washing the resin with water, it was eluted with 2N aqueous ammonia, and 477
The fractions containing -2h are concentrated to 301 under reduced pressure. The concentrated solution was adjusted to pH 8. with 6N hydrochloric acid. After adjusting to O, it was passed through a column packed with Amberlite IRC-50 (NH4+ type) 41, washed with water, and eluted with 2N aqueous ammonia.
The fraction containing h is concentrated to dryness under reduced pressure. Dissolve the residue in water, pH 8. After adjusting to O, Amberlight CG-5
The column was passed through a column packed with 1000 mt of 0 type I (NH4+ type) (Rohm & Haas USA), washed with water, and eluted with 0.1N aqueous ammonia containing 0.2M ammonium chloride. After a few trace components are eluted first, a section containing 477-2h is eluted. The fractions were collected and adjusted to pH 7.8 with 6N monohydrochloric acid, passed through a column packed with Amberlite IRC-50 (NH4+ type) 200rfL1, washed with water, and eluted with 1N aqueous ammonia. The fraction containing 477-2h was concentrated and freeze-dried to yield 7.5 tons of powder.

40007のシリカゲル(WakOgelC−200、
和光純薬工業製)をn−ブタノール、エタノール,、濃
アンモニア水(8:10:7)に懸濁し、カラムにつめ
、これに粗粉末7.5fを同じ組成のソルベントに懸濁
したものを乗せ、同一組成のソルベントにて溶出する。
40007 silica gel (WakOgelC-200,
Wako Pure Chemical Industries, Ltd.) was suspended in n-butanol, ethanol, and concentrated ammonia water (8:10:7) and packed into a column, and 7.5 f of coarse powder was suspended in a solvent of the same composition. eluted with a solvent of the same composition.

溶出速度66.7m1/Mmで溶出画分を500m1づ
つ分取する。477−2hを含む画分を集め濃縮乾固後
、残渣を少量の水に溶かし、PHを7.8に調整した後
、アンバーライトIRC−50(NH4+型)100T
IL1を充填したカラムに通し、水洗後1Nアンモニア
水で溶出し、477−2hを含む区分を集めて減圧下で
濃縮後、凍結乾燥を行うと477−2hの遊離塩基4.
3tの精製標品が得られる。
The elution fraction is separated into 500 ml portions at an elution rate of 66.7 ml/Mm. The fractions containing 477-2h were collected and concentrated to dryness. The residue was dissolved in a small amount of water and the pH was adjusted to 7.8, followed by Amberlite IRC-50 (NH4+ type) 100T.
Pass through a column packed with IL1, wash with water, elute with 1N aqueous ammonia, collect fractions containing 477-2h, concentrate under reduced pressure, and freeze-dry to obtain the free base of 477-2h.
3t of purified sample is obtained.

辷施例 2 実施例1で得られた477−2h遊離塩基1r〈10m
1の水に溶かし、0.5N硫酸で中和する。
Example 2 477-2h free base obtained in Example 1 1r<10m
Dissolve in 1 water and neutralize with 0.5N sulfuric acid.

Claims (1)

【特許請求の範囲】 1 式 ▲数式、化学式、表等があります▼ で表わされる新規物質477−2hおよびその酸付加塩
。 2 ミクロモノスポラ属に属し、477−2hを生産す
る能力を有する微生物を栄養培地に477−2hが実質
的に検出できる迄培養し、477−2hを培地中に蓄積
せしめ、培養液から477−2hを単離回収することを
特徴とする477−2hの製造法。
[Claims] 1. A novel substance 477-2h represented by the formula ▲ Numerical formula, chemical formula, table, etc. ▼ and its acid addition salt. 2. A microorganism belonging to the genus Micromonospora and having the ability to produce 477-2h is cultured in a nutrient medium until 477-2h can be substantially detected, 477-2h is accumulated in the medium, and 477-2h is extracted from the culture solution. A method for producing 477-2h, which comprises isolating and recovering 2h.
JP3968278A 1978-04-06 1978-04-06 New substance 477-2h and its manufacturing method Expired JPS599159B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3968278A JPS599159B2 (en) 1978-04-06 1978-04-06 New substance 477-2h and its manufacturing method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3968278A JPS599159B2 (en) 1978-04-06 1978-04-06 New substance 477-2h and its manufacturing method

Publications (2)

Publication Number Publication Date
JPS54132550A JPS54132550A (en) 1979-10-15
JPS599159B2 true JPS599159B2 (en) 1984-02-29

Family

ID=12559850

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3968278A Expired JPS599159B2 (en) 1978-04-06 1978-04-06 New substance 477-2h and its manufacturing method

Country Status (1)

Country Link
JP (1) JPS599159B2 (en)

Also Published As

Publication number Publication date
JPS54132550A (en) 1979-10-15

Similar Documents

Publication Publication Date Title
JPS6254433B2 (en)
JPS599159B2 (en) New substance 477-2h and its manufacturing method
US4376761A (en) Homocitric acid oligoriboside derivative for prevention of dental caries
JPS6133194A (en) Novel anthracycline antibiotic substance
US3975235A (en) Process for the production of cephamycin type antibiotic substances
JPS588397B2 (en) Novel mitomycin derivative and its production method
JPS5831196B2 (en) SF-1771 Bushitsuno Seizouhou
JPH0670019B2 (en) New antibiotic SF2197C substance and its manufacturing method
US4298690A (en) Antibiotics XK-62-3 and XK-62-4 and process for production thereof
JPS61141889A (en) Novel antibiotic sf-2197b and its preparation
JPS59198982A (en) Novel antibiotic substance sf-2240 and its preparation
JPS6219599A (en) Novel macrolide antibiotic m119
JPS5913192B2 (en) New substance UAA-3 and its manufacturing method
JPS5849237B2 (en) Method for producing dientamicin C/a
JP3100785B2 (en) Novel avermectin derivative, method for producing the same and microorganism producing the same
JPS6332798B2 (en)
JPS5898095A (en) Production of demyssinosyl-mycinamicin 4
JPS584039B2 (en) Antibiotic DMB and its manufacturing method
JPH0123473B2 (en)
JPS6043357B2 (en) New substance SU-1 and its manufacturing method
JPS597314B2 (en) Manufacturing method for new antibiotics
JPS5914039B2 (en) Houteimycin KO and its manufacturing method
JPS5927898A (en) Novel antibiotic and its preparation
JPS5922513B2 (en) New substance SUM-4 and its manufacturing method
JPS5830036B2 (en) Antibiotic SU-2 and its manufacturing method